To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
41 Newest Market Studies about the topic lymphoma
rss
Non-Hodgkin Lymphoma – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Non-Hodgkin Lymphoma - Pipeline Review, H1 2012', provides an overview of the Non-Hodgkin Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Non-Hodgkin Lymphoma, complete with latest updates, and special ...
B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Global Markets Direct’s, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic ...
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
GBI Research, the leading business intelligence provider, has released its latest research, “Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline” which provides insights into the global oncology pipeline. ...
CNS Lymphoma – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'CNS Lymphoma - Pipeline Review, H2 2012', provides an overview of the CNS Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for CNS Lymphoma, complete with latest updates, and special features on late-stage ...
Follicular Lymphoma – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H2 2012', provides an overview of the Follicular Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Follicular Lymphoma, complete with latest updates, and special ...
Follicular Lymphoma – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H1 2012', provides an overview of the Follicular Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Follicular Lymphoma, complete with latest updates, and special ...
Hodgkin Lymphoma – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'Hodgkin Lymphoma - Pipeline Review, H2 2012', provides an overview of the Hodgkin Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Hodgkin Lymphoma, complete with latest updates, and special features on ...
Mantle Cell Lymphoma – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'Mantle Cell Lymphoma - Pipeline Review, H2 2012', provides an overview of the Mantle Cell Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Mantle Cell Lymphoma, complete with latest updates, and special ...
Lymphoma – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Lymphoma - Pipeline Review, H1 2012', provides an overview of the Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Lymphoma, complete with latest updates, and special features on late-stage and ...
Follicular Lymphoma Global Clinical Trials Review, H1, 2012
Introduction GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2012" provides data on the Follicular Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Follicular Lymphoma. It ...
Netmeeting
